About the Product

Description


Uriviga TL 4 Capsule containing Tamsulosin and Tolterodine is used for the management of urinary symptoms associated with lower urinary tract disorders and bladder dysfunction. It helps improve urinary flow, reduce frequency and urgency, and support better bladder control.

Tamsulosin works by relaxing the smooth muscles of the prostate and bladder neck to improve urine flow, while Tolterodine helps reduce involuntary bladder contractions and symptoms of overactive bladder. Together, they provide effective urological support.

The capsule is widely prescribed in urology practice for patients experiencing urinary urgency, frequency, nocturia, and other lower urinary tract symptoms, leading to consistent prescription demand.

With increasing prevalence of urological disorders and growing demand for advanced bladder management therapies, this product offers strong business potential for retailers and distributors. Its dual-action formulation, established therapeutic value, and steady market demand make it a reliable product for growth in the urology care segment.

Some patients may experience dry mouth, dizziness, headache, constipation, blurred vision, fatigue, or nasal congestion. Rarely, urinary retention, palpitations, severe allergic reactions, or significant reductions in blood pressure may occur and require immediate medical attention.

Uriviga TL 4 Capsule is indicated for lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH), overactive bladder, urinary urgency, urinary frequency, nocturia, and urge urinary incontinence. It helps improve urine flow, reduce frequent urination, and support better bladder storage function.

This medicine should be used strictly under medical supervision. Use cautiously in patients with glaucoma, urinary retention, liver disease, kidney impairment, or cardiovascular disorders. Patients may experience dizziness, particularly when rising from a sitting or lying position, and should exercise caution while driving or operating machinery.

Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the capsules in their original packaging and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions